181 related articles for article (PubMed ID: 36504898)
1. MECP2 promotes the migration and invasion of gastric cancer cells by modulating the Notch1/c-Myc/mTOR signaling pathways by suppressing FBXW7 transcription.
Zhao L; Wang X; Yang J; Jiang Q; Zhang J; Wu F; Ni L; Tong D; Huang C
Am J Cancer Res; 2022; 12(11):5183-5204. PubMed ID: 36504898
[TBL] [Abstract][Full Text] [Related]
2. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
Lu H; Yao B; Wen X; Jia B
BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
[TBL] [Abstract][Full Text] [Related]
4. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
[TBL] [Abstract][Full Text] [Related]
5. ZC3H15 promotes gastric cancer progression by targeting the FBXW7/c-Myc pathway.
Hou J; Huang P; Lan C; Geng S; Xu M; Liu Y; Chang H; Wang Z; Gu H; Wang Y; Yang G; Cui H
Cell Death Discov; 2022 Jan; 8(1):32. PubMed ID: 35064102
[TBL] [Abstract][Full Text] [Related]
6. FBXW7 inhibits invasion, migration and angiogenesis in ovarian cancer cells by suppressing VEGF expression through inactivation of β-catenin signaling.
Zhong L; Pan Y; Shen J
Exp Ther Med; 2021 May; 21(5):514. PubMed ID: 33791023
[TBL] [Abstract][Full Text] [Related]
7. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
8. Demethylzeylasteral inhibits proliferation, migration, and invasion through FBXW7/c-Myc axis in gastric cancer.
Li Y; Su Y; Zhao Y; Hu X; Zhao G; He J; Wan S; Lü M; Cui H
MedComm (2020); 2021 Sep; 2(3):467-480. PubMed ID: 34766156
[TBL] [Abstract][Full Text] [Related]
9. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
[TBL] [Abstract][Full Text] [Related]
10. MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1.
Zhao LY; Tong DD; Xue M; Ma HL; Liu SY; Yang J; Liu YX; Guo B; Ni L; Liu LY; Qin YN; Wang LM; Zhao XG; Huang C
Oncogenesis; 2017 Jul; 6(7):e368. PubMed ID: 28759023
[TBL] [Abstract][Full Text] [Related]
11. MeCP2 regulated glycogenes contribute to proliferation and apoptosis of gastric cancer cells.
Qin Y; Zhao L; Wang X; Tong D; Hoover C; Wu F; Liu Y; Wang L; Liu L; Ni L; Song T; Huang C
Glycobiology; 2017 Apr; 27(4):306-317. PubMed ID: 28100567
[TBL] [Abstract][Full Text] [Related]
12. MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway.
Qin Y; Ma X; Guo C; Cai S; Ma H; Zhao L
Cancer Cell Int; 2022 Feb; 22(1):86. PubMed ID: 35180871
[TBL] [Abstract][Full Text] [Related]
13. miR-449c-5p availability is antagonized by circ-NOTCH1 for MYC-induced NOTCH1 upregulation as well as tumor metastasis and stemness in gastric cancer.
Zhao X; Zhong Q; Cheng X; Wang S; Wu R; Leng X; Shao L
J Cell Biochem; 2020 Oct; 121(10):4052-4063. PubMed ID: 31943342
[TBL] [Abstract][Full Text] [Related]
14. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
[TBL] [Abstract][Full Text] [Related]
15. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
[TBL] [Abstract][Full Text] [Related]
16. ENKUR recruits FBXW7 to ubiquitinate and degrade MYH9 and further suppress MYH9-induced deubiquitination of β-catenin to block gastric cancer metastasis.
Liu J; Liu Z; Yan W; Yang H; Fang S; Deng S; Wen Y; Shen P; Li Y; Hou R; Liu X; Huang T; Li R; Zheng D; Liu Z; Fang W
MedComm (2020); 2022 Dec; 3(4):e185. PubMed ID: 36448053
[TBL] [Abstract][Full Text] [Related]
17. Increase in Cisplatin Resistance by MeCP2 in Human Gastric Cancer through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription.
Guo B; Cai S; Li W; Guo C; Liu Y; Ma X; Ma H; Zhao L
Curr Cancer Drug Targets; 2022; 22(5):414-425. PubMed ID: 35209822
[TBL] [Abstract][Full Text] [Related]
18. MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.
Tong D; Zhang J; Wang X; Li Q; Liu LY; Yang J; Guo B; Ni L; Zhao L; Huang C
Oncogenesis; 2020 Jun; 9(5):56. PubMed ID: 32483207
[TBL] [Abstract][Full Text] [Related]
19.
Close V; Close W; Kugler SJ; Reichenzeller M; Yosifov DY; Bloehdorn J; Pan L; Tausch E; Westhoff MA; Döhner H; Stilgenbauer S; Oswald F; Mertens D
Blood; 2019 Feb; 133(8):830-839. PubMed ID: 30510140
[No Abstract] [Full Text] [Related]
20. MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect.
Tong D; Zhao L; He K; Sun H; Cai D; Ni L; Sun R; Chang S; Song T; Huang C
Oncotarget; 2016 Jun; 7(23):34845-59. PubMed ID: 27166996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
